Syndax Pharmaceuticals (SNDX) PT Raised to $34 at BTIG
Tweet Send to a Friend
BTIG analyst Robert Hazlett raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $34.00 (from $32.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
